Robin Kramer - Jul 1, 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Accounting Officer
Signature
/s/ Wendell Taylor, attorney-in-fact for Robin Kramer
Stock symbol
BIIB
Transactions as of
Jul 1, 2022
Transactions value $
-$15,587
Form type
4
Date filed
7/6/2022, 07:33 PM
Previous filing
Apr 15, 2022
Next filing
Dec 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +252 +13.7% $0.00 2.09K Jul 1, 2022 Direct F1
transaction BIIB Common Stock Tax liability -$15.6K -74 -3.54% $210.63 2.02K Jul 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -252 -50% $0.00 252 Jul 1, 2022 Common Stock 252 $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 102.4003 shares acquired under the Biogen Inc. employee stock purchase plan.
F2 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 07/01/2020.